- Home
- MRNA vs SNAP Comparison
MRNA vs SNAP Comparison
Compare MRNA & SNAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- SNAP
- Stock Information
- Founded
- MRNA 2010
- SNAP 2010
- Country
- MRNA United States
- SNAP United States
- Employees
- MRNA N/A
- SNAP N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- SNAP Computer Software: Programming Data Processing
- Sector
- MRNA Health Care
- SNAP Technology
- Exchange
- MRNA Nasdaq
- SNAP Nasdaq
- Market Cap
- MRNA 16.0B
- SNAP 19.1B
- IPO Year
- MRNA 2018
- SNAP 2017
- Fundamental
- Price
- MRNA $34.06
- SNAP $10.86
- Analyst Decision
- MRNA Hold
- SNAP Hold
- Analyst Count
- MRNA 20
- SNAP 29
- Target Price
- MRNA $76.35
- SNAP $13.95
- AVG Volume (30 Days)
- MRNA 10.7M
- SNAP 29.8M
- Earning Date
- MRNA 02-20-2025
- SNAP 02-04-2025
- Dividend Yield
- MRNA N/A
- SNAP N/A
- EPS Growth
- MRNA N/A
- SNAP N/A
- EPS
- MRNA N/A
- SNAP N/A
- Revenue
- MRNA $5,081,000,000.00
- SNAP $5,165,402,000.00
- Revenue This Year
- MRNA N/A
- SNAP $18.58
- Revenue Next Year
- MRNA N/A
- SNAP $13.46
- P/E Ratio
- MRNA N/A
- SNAP N/A
- Revenue Growth
- MRNA N/A
- SNAP 13.66
- 52 Week Low
- MRNA $31.94
- SNAP $8.29
- 52 Week High
- MRNA $170.47
- SNAP $17.50
- Technical
- Relative Strength Index (RSI)
- MRNA 34.88
- SNAP 42.03
- Support Level
- MRNA $33.34
- SNAP $11.29
- Resistance Level
- MRNA $35.68
- SNAP $12.35
- Average True Range (ATR)
- MRNA 2.46
- SNAP 0.61
- MACD
- MRNA -0.75
- SNAP -0.07
- Stochastic Oscillator
- MRNA 12.49
- SNAP 10.86
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About SNAP Snap Inc.
Snap is a technology company best known for its marquis social media application Snapchat, a visual messaging application that has amassed hundreds of millions of users. The app was initially only used to communicate with family and friends through photographs and short videos (known as "Snaps"). Users can now enjoy augmented reality, or AR, lenses, content from famous creators and celebrities, updates about local events, and more. Although the app offers a paid subscription option with premium features, advertising sales produce most of the app's revenue. The firm also sells wearable devices called AR Spectacles, which can capture photos and videos overlayed with AR lenses, but these make up a small portion of Snap's overall sales.